Connection

Christopher Nielsen to Humans

Back to Details
This is a "connection" page, showing publications Christopher Nielsen has written about Humans.
Christopher Nielsen
Connection Strength
0.150
Humans
  1. Long-Term Survival After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Experience. J Invasive Cardiol. 2021 Oct; 33(10):E769-E776.
    View in: PubMed
    Score: 0.030
  2. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients. Catheter Cardiovasc Interv. 2013 Nov 01; 82(5):838-45.
    View in: PubMed
    Score: 0.017
  3. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures. Clin Cardiol. 2003 Jun; 26(6):275-9.
    View in: PubMed
    Score: 0.008
  4. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am Heart Hosp J. 2003; 1(1):83-90.
    View in: PubMed
    Score: 0.008
  5. Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy. Cardiol Rev. 2002 Mar-Apr; 10(2):108-18.
    View in: PubMed
    Score: 0.008
  6. Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool. Catheter Cardiovasc Interv. 2021 08 01; 98(2):393-400.
    View in: PubMed
    Score: 0.007
  7. Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study. Circ Heart Fail. 2020 11; 13(11):e007981.
    View in: PubMed
    Score: 0.007
  8. The role of electrophysiologic study in high-risk patients with new-onset conduction disturbances following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. J Cardiovasc Electrophysiol. 2020 09; 31(9):2522-2525.
    View in: PubMed
    Score: 0.007
  9. Relation of Lymphangiogenic Factor Vascular Endothelial Growth Factor-D to Elevated Pulmonary Artery Wedge Pressure. Am J Cardiol. 2019 09 01; 124(5):756-762.
    View in: PubMed
    Score: 0.006
  10. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial. JAMA Cardiol. 2018 10 01; 3(10):968-977.
    View in: PubMed
    Score: 0.006
  11. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial. Circulation. 2018 01 23; 137(4):364-375.
    View in: PubMed
    Score: 0.006
  12. Left ventricular end-diastolic pressure affects measurement of fractional flow reserve. Cardiovasc Revasc Med. 2013 Jul-Aug; 14(4):218-22.
    View in: PubMed
    Score: 0.004
  13. Comparison of lipid deposition at coronary bifurcations versus at nonbifurcation portions of coronary arteries as determined by near-infrared spectroscopy. Am J Cardiol. 2013 Aug 01; 112(3):369-72.
    View in: PubMed
    Score: 0.004
  14. Comparison of percutaneous coronary intervention safety before and during the establishment of a transradial program at a teaching hospital. Am J Cardiol. 2012 Apr 15; 109(8):1154-9.
    View in: PubMed
    Score: 0.004
  15. Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
    View in: PubMed
    Score: 0.004
  16. Takotsubo cardiomyopathy in a patient with previously undiagnosed hypertrophic cardiomyopathy with obstruction. Cardiovasc Revasc Med. 2011 Jan-Feb; 12(1):70.e1-5.
    View in: PubMed
    Score: 0.004
  17. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
    View in: PubMed
    Score: 0.003
  18. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008 Oct; 1(5):561-70.
    View in: PubMed
    Score: 0.003
  19. Giant Kawasaki coronary artery aneurysm: cardiac imaging evolution. Eur Heart J. 2008 Dec; 29(24):3042.
    View in: PubMed
    Score: 0.003
  20. Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol. 2007 Nov 15; 100(10):1592-7.
    View in: PubMed
    Score: 0.003
  21. Significant coronary artery stenosis: comparison on per-patient and per-vessel or per-segment basis at 64-section CT angiography. Radiology. 2007 Jul; 244(1):112-20.
    View in: PubMed
    Score: 0.003
  22. Does two-segment image reconstruction at 64-section CT coronary angiography improve image quality and diagnostic accuracy? Radiology. 2007 Jul; 244(1):121-9.
    View in: PubMed
    Score: 0.003
  23. Treatment of coronary artery disease in hemodialysis patients: PTCA vs. stent. Catheter Cardiovasc Interv. 2001 Dec; 54(4):459-63.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.